Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Psoriasis rates in transgender people are similar to the general population, but hormone therapy might affect it.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Many transgender men on testosterone therapy experience hair loss.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Testosterone treatment may affect heart response to stress in transgender men.

The conclusion is that supportive environments are crucial for the mental health and well-being of transgender individuals during gender transition or de-transition.

The transgender community in India has specific skin care needs and struggles to access dermatological services due to discrimination and financial issues.

Transgender patients with hair loss need personalized treatment plans considering their unique needs.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.